Owners of this ASX 200 share are soon going to receive a bigger dividend

Investors in this healthcare company are about to get a healthy cash boost.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Sonic Healthcare shares have gone ex-dividend
  • Investors will receive a 42 cents per share dividend in two weeks
  • The company remains much more profitable since the start of the COVID pandemic

The Sonic Healthcare Ltd (ASX: SHL) share price is in the red — and has been for most of today's trading — after the S&P/ASX 200 Index (ASX: XJO) healthcare share went ex-dividend.

Last month was reporting season, when investors learned how their companies had performed in the period to December 2022.

Some businesses also declared their latest dividends.

Sonic Healthcare was one of the businesses that announced its dividend, with another increase for investors.

A young woman wearing a blue blouse with white polkadots holds her phone up with an intrigued and happy look on her face as she reads some news.

Image source: Getty Images

Sonic Healthcare shares goes ex-dividend

The board of the ASX 200 share decided to declare an interim dividend of 42 cents per share. That represents an increase of 5% compared to the prior corresponding period.

Sonic Healthcare shares went ex-dividend today, meaning that investors who buy shares today aren't entitled to that 42 cents dividend per share. This will be paid on 22 March 2023.

Investors who were too late to buy shares will need to wait another six months for the next half-year dividend. However, the business has a "progressive dividend policy", so the next dividend may also be higher than what was paid in the prior corresponding period of the previous financial year.

How was the ASX 200 share's dividend funded?

The ASX 200 share reported that in the first six months of the 2023 financial year, its total revenue was $4.08 billion and earnings per share (EPS) was 80.9 cents. Those numbers were up 22% and 52% respectively, compared to the pre-COVID result of the FY20 first half.

Those numbers included its base business revenue of $3.7 billion, which was up 9% year over year. The base business margins were "in line" with pre-pandemic levels. It's also benefiting from catch-up testing which is now going up after the pandemic and its extensive COVID testing regimes.

The business is pursuing new contracts and potential acquisitions which could help it grow further from here.

Sonic Healthcare share price snapshot

Since the beginning of 2023, the ASX 200 healthcare share has risen around 10%.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two lab workers fist pump each other.
Healthcare Shares

Neuren share price in focus after DAYBU wins EU approval for Rett syndrome

Neuren shares are on watch after DAYBU (trofinetide) won European approval, unlocking commercial milestones and revenue opportunities.

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Earnings Results

Nanosonics posts FY26 revenue growth and prepares to launch CORIS

Nanosonics FY26 earnings show steady revenue growth and set the stage for the CORIS commercial launch.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Special dividend: Is now the time to buy NIB shares for income?

NIB shares now offer a yield well over 4%.

Read more »

Three healthcare workers standing together and smiling.
Healthcare Shares

Regis Healthcare reports higher FY26 profits and dividend

Regis Healthcare delivered higher revenue, profit and dividends in FY26, with occupancy and acquisitions driving strong results.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Healthcare Shares

Could CSL shares really hit $200? Experts reveal their 12-month targets

Brokers warn CSL’s spectacular rebound doesn’t guarantee further gains.

Read more »

Five healthcare workers standing together and smiling.
ASX Share Market News

ASX 200 healthcare shares soar 9% amid notable FY26 reports from CSL, Pro Medicus

Healthcare outperformed while the ASX 200 weakened as earnings season continued last week.

Read more »

young female doctor with digital tablet looking confused.
Healthcare Shares

Telix shares are tumbling. Is the stock finally at fair value?

Telix's sell-off reflects valuation, competition, and heightened growth expectations.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Why I'd buy Medibank shares for the dividend yield

Medibank is providing investors with very healthy dividends.

Read more »